{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:20:13Z","timestamp":1793215213166,"version":"4.5.0"},"reference-count":461,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jhep.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:41:11Z","timestamp":1762962071000},"page":"399-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["EASL Clinical Practice Guidelines on vascular diseases of the liver"],"prefix":"10.1016","volume":"84","author":[{"given":"Pierre-Emmanuel","family":"Rautou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Moga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Hernandez-Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwa","family":"Darwish Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Garcia-Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"McLin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vilgrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.08.001_bib1","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1160\/TH16-10-0781","article-title":"Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome","volume":"117","author":"Ageno","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2025.08.001_bib2","first-page":"931","article-title":"The epidemiology of Budd-Chiari syndrome in France","volume":"50","author":"Ollivier-Hourmand","year":"2018","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jhep.2018.10.011","article-title":"Clinical practice guidelines of the European association for the study of the liver - advancing methodology but preserving practicability","volume":"70","author":"Cornberg","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib4","unstructured":"Anon. OCEBM Levels of Evidence Working Group\u2217. \u201cThe Oxfords Levels of Evidence 2\u201d. Oxford Centre for Evidence-Based Medicine. Available at: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence [Accessed December 12, 2024]."},{"key":"10.1016\/j.jhep.2025.08.001_bib5","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1365-2036.2010.04454.x","article-title":"The epidemiology and clinical features of portal vein thrombosis: a multicentre study","volume":"32","author":"Rajani","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib6","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","author":"Ageno","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"Etiology, management, and outcome of the Budd-Chiari syndrome","volume":"151","author":"Darwish","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2015-03-631119","article-title":"Splanchnic venous thrombosis is a marker of cancer and a prognostic factor for cancer survival","volume":"126","author":"S\u00f8gaard","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2025.08.001_bib9","first-page":"200","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jhep.2025.08.001_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMra2207738","article-title":"Primary budd-chiari syndrome","volume":"388","author":"Garcia-Pag\u00e1n","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib11","article-title":"Management of splanchnic vein thrombosis","volume":"5","author":"Elkrief","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib12","article-title":"Splanchnic vein thrombosis associated with SARS-CoV-2 infection: a VALDIG case-control study","volume":"5","author":"Deltenre","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib13","article-title":"Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: observations from a VALDIG multicenter study","volume":"6","author":"Perez-Campuzano","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhep.2021.09.011","article-title":"Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease","volume":"76","author":"De Broucker","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jhep.2015.08.024","article-title":"Central obesity is associated with non-cirrhotic portal vein thrombosis","volume":"64","author":"Bureau","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12657","article-title":"Thrombosis in myeloproliferative neoplasms during cytoreductive and antithrombotic drug treatment","volume":"6","author":"Barbui","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jhep.2025.08.001_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/bloodadvances.2020003628","article-title":"A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms","volume":"5","author":"Hamuly\u00e1k","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jhep.2025.08.001_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13023-014-0153-1","article-title":"Behcet\u2019s disease in Budd-Chiari syndrome","volume":"9","author":"Desbois","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2025.08.001_bib19","first-page":"767","article-title":"Vascular complications of Beh\u00e7et disease","volume":"112","author":"Tazi","year":"2021","journal-title":"Minerva Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12072-018-9880-z","article-title":"Budd-Chiari syndrome has different presentations and disease severity during adolescence","volume":"12","author":"Shukla","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2025.08.001_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S0004-28032012000100012","article-title":"Portal vein thrombosis in children and adolescents: 20 years experience of a pediatric hepatology reference center","volume":"49","author":"Ferri","year":"2012","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib22","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.jtha.2023.05.014","article-title":"Anticoagulant treatment for pediatric splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"21","author":"Cohen","year":"2023","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.jhep.2025.08.001_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0168-8278(02)00434-8","article-title":"Budd-Chiari syndrome: a review by an expert panel","volume":"38","author":"Janssen","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib24","first-page":"995","article-title":"Three-fold increased risk of death in Budd-chiari syndrome compared to matched controls: a population-based cohort study","volume":"21","author":"\u00c5berg","year":"2023","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jhep.2025.08.001_bib25","first-page":"253","article-title":"Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience","volume":"29","author":"Rajani","year":"2009","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-8278(95)80252-5","article-title":"Epidemiological and clinical features of Budd-Chiari syndrome in Japan","volume":"22","author":"Okuda","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12072-020-10115-0","article-title":"Acute liver failure in Budd-Chiari syndrome and a model to predict mortality","volume":"15","author":"Thuluvath","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2025.08.001_bib28","first-page":"135","article-title":"Budd-chiari syndrome causing acute liver failure: a multicenter case series","volume":"23","author":"Parekh","year":"2017","journal-title":"Liver Transpl Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc"},{"key":"10.1016\/j.jhep.2025.08.001_bib29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0016-5085(94)90765-X","article-title":"The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases","volume":"106","author":"Hadengue","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib30","first-page":"382","article-title":"Ultrasonography in liver vascular disease","volume":"39","author":"De Gottardi","year":"1980","journal-title":"Ultraschall Med Stuttg Ger"},{"key":"10.1016\/j.jhep.2025.08.001_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2008.04.025","article-title":"Ultrasonography in patients with Budd-Chiari syndrome: diagnostic signs and prognostic implications","volume":"49","author":"Boozari","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib32","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190847","article-title":"Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis","volume":"93","author":"Gupta","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11239-013-0959-z","article-title":"Small hepatic veins Budd-Chiari syndrome","volume":"37","author":"Riggio","year":"2014","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jhep.2025.08.001_bib34","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.21354","article-title":"Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome","volume":"44","author":"Plessier","year":"2006","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib35","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib36","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/MEG.0000000000000632","article-title":"Increased prevalence of heparin-induced thrombocytopenia in patients with Budd-Chiari syndrome: a retrospective analysis","volume":"28","author":"Zaman","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhep.2010.06.019","article-title":"Bleeding in patients with Budd-Chiari syndrome","volume":"54","author":"Rautou","year":"2011","journal-title":"J Hepatol"},{"issue":"22","key":"10.1016\/j.jhep.2025.08.001_bib38","article-title":"Outcome of Budd-chiari syndrome patients treated with direct oral anticoagulants: an Austrian multicenter study","volume":"S1542\u20133565","author":"Semmler","year":"2022","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jhep.2025.08.001_bib39","first-page":"694","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"De Gottardi","year":"2017","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"European Association for the Study of the Liver","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib43","first-page":"111","article-title":"Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome","volume":"37","author":"Tripathi","year":"2017","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib44","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/gut.2005.071423","article-title":"Favourable medium term outcome following hepatic vein recanalisation and\/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome","volume":"55","author":"Eapen","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.08.001_bib45","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S2468-1253(19)30177-3","article-title":"Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial","volume":"4","author":"Wang","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2003.09.028","article-title":"Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature","volume":"40","author":"Sharma","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib47","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1160\/TH08-01-0015","article-title":"Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis","volume":"100","author":"Smalberg","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2025.08.001_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2006.08.016","article-title":"Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome","volume":"46","author":"Bachet","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib49","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2008.05.051","article-title":"TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients","volume":"135","author":"Garcia-Pag\u00e1n","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0168-8278(03)00118-1","article-title":"TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience","volume":"38","author":"Mancuso","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1148\/radiol.2016152641","article-title":"Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-chiari syndrome","volume":"283","author":"Hayek","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib52","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/apt.12668","article-title":"Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome","volume":"39","author":"Tripathi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib53","first-page":"249","article-title":"Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome","volume":"28","author":"Darwish Murad","year":"2008","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib54","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2005.12.002","article-title":"Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres","volume":"44","author":"Mentha","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib55","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/ajt.16410","article-title":"Outcomes of status 1 liver transplantation for Budd-Chiari Syndrome with fulminant hepatic failure","volume":"21","author":"Alukal","year":"2021","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib56","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001407","article-title":"Liver transplantation for Budd-chiari syndrome in the MELD Era","volume":"8","author":"Alqahtani","year":"2022","journal-title":"Transpl Direct"},{"key":"10.1016\/j.jhep.2025.08.001_bib57","first-page":"144","article-title":"Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome","volume":"14","author":"Ulrich","year":"2008","journal-title":"Liver Transpl Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc"},{"key":"10.1016\/j.jhep.2025.08.001_bib58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/TP.0b013e3182247b05","article-title":"Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology","volume":"92","author":"Chinnakotla","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2025.08.001_bib59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1399-0012.2005.00374.x","article-title":"High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome","volume":"19","author":"Cruz","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib60","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/HEP.0000000000000778","article-title":"Recent outcomes of liver transplantation for Budd-Chiari syndrome: a study of the European Liver Transplant Registry (ELTR) and affiliated centers","volume":"80","author":"Dongelmans","year":"2024","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib61","first-page":"2042","article-title":"Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms","volume":"35","author":"Potthoff","year":"2015","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib62","doi-asserted-by":"crossref","first-page":"591","DOI":"10.12659\/AOT.890834","article-title":"Myeloproliferative neoplasms and recurrent thrombotic events in patients undergoing liver transplantation for Budd-Chiari syndrome: a single-center experience","volume":"19","author":"Oldakowska-Jedynak","year":"2014","journal-title":"Ann Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib63","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.transproceed.2017.04.028","article-title":"Living-donor liver transplantation for Budd-chiari syndrome: case series","volume":"49","author":"Karaca","year":"2017","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2025.08.001_bib64","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/j.1600-6143.2006.01505.x","article-title":"Surgical techniques and long-term outcomes of living donor liver transplantation for Budd-Chiari syndrome","volume":"6","author":"Yamada","year":"2006","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib65","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1007\/s00268-022-06709-4","article-title":"Living donor liver transplantation for Budd-chiari syndrome: a Propensity score-matched analysis","volume":"46","author":"Gunasekaran","year":"2022","journal-title":"World J Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.510300125","article-title":"Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting","volume":"30","author":"Zeitoun","year":"1999","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib67","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0168-8278(03)00323-4","article-title":"Clinicopathological forms and prognostic index in Budd-Chiari syndrome","volume":"39","author":"Langlet","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib68","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.20064","article-title":"Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome","volume":"39","author":"Darwish","year":"2004","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib69","first-page":"867","article-title":"Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?","volume":"13","author":"Darwish Murad","year":"2007","journal-title":"Liver Transpl Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc"},{"key":"10.1016\/j.jhep.2025.08.001_bib70","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ajg.2009.63","article-title":"Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management","volume":"104","author":"Rautou","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib71","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1148\/radiology.210.2.r99fe13443","article-title":"Hepatic nodules in Budd-Chiari syndrome: imaging features","volume":"210","author":"Vilgrain","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib72","article-title":"Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome","volume":"2","author":"Van Wettere","year":"2020","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diii.2021.09.001","article-title":"MR imaging features and long-term evolution of benign focal liver lesions in Budd-Chiari syndrome and Fontan-associated liver disease","volume":"103","author":"Panvini","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.jhep.2025.08.001_bib74","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1007\/s00261-018-1502-7","article-title":"Benign and malignant hepatocellular lesions in patients with vascular liver diseases","volume":"43","author":"Vilgrain","year":"2018","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.jhep.2025.08.001_bib75","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.2007.139477","article-title":"Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors","volume":"57","author":"Moucari","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.08.001_bib76","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jhep.2015.06.017","article-title":"Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders","volume":"63","author":"Sempoux","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib77","first-page":"2689","article-title":"Minimal risk of hepatocellular carcinoma in noncirrhotic Budd-chiari syndrome: a three-decade population-based study","volume":"21","author":"Wester","year":"2023","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jhep.2025.08.001_bib78","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3748\/wjg.v18.i16.1946","article-title":"Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea","volume":"18","author":"Park","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib79","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00042737-200403000-00012","article-title":"Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma","volume":"16","author":"Shin","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib80","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2019.01.009","article-title":"Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome","volume":"70","author":"Van Wettere","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib81","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib82","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3760\/cma.j.issn.0366-6999.20130898","article-title":"Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma","volume":"126","author":"Wang","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jhep.2025.08.001_bib83","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1148\/radiol.09090738","article-title":"Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE","volume":"254","author":"Gwon","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib84","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-230X-13-105","article-title":"Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization","volume":"13","author":"Liu","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib85","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00261-016-0923-4","article-title":"Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases","volume":"42","author":"Dou","year":"2017","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.jhep.2025.08.001_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3476(88)80524-9","article-title":"Budd-Chiari syndrome in children: report of 22 cases","volume":"113","author":"Gentil-Kocher","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2025.08.001_bib87","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MPG.0b013e31814d4e0a","article-title":"Budd-Chiari syndrome and essential thrombocythemia in a child: favorable outcome after transjugular intrahepatic portosystemic shunt","volume":"46","author":"Hermeziu","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2025.08.001_bib88","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00270-001-0098-3","article-title":"Transjugular intrahepatic portosystemic shunt in a child with Budd-Chiari syndrome: technical modification and extended followup","volume":"25","author":"Carnevale","year":"2002","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib89","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00270-009-9647-y","article-title":"Hepatic veins and inferior vena cava thrombosis in a child treated by transjugular intrahepatic portosystemic shunt","volume":"33","author":"Carnevale","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib90","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/MEG.0000000000000144","article-title":"Budd-Chiari syndrome in children: clinical features, percutaneous radiological intervention, and outcome","volume":"26","author":"Kathuria","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib91","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00246-012-0188-9","article-title":"Percutaneous recanalization of an occluded hepatic vein in a difficult subset of pediatric Budd-Chiari syndrome","volume":"33","author":"Chaudhuri","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib92","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.08.001_bib93","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"Yerdel","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2025.08.001_bib94","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2468-1253(24)00155-9","article-title":"Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies","volume":"9","author":"Elkrief","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib95","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib96","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib97","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib98","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.32367","article-title":"Contrast-enhanced CT and liver surface nodularity for the diagnosis of porto-sinusoidal vascular disorder: a case-control study","volume":"76","author":"Valainathan","year":"2022","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib99","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.31688","article-title":"Liver stiffness by transient elastography to detect porto-sinusoidal vascular liver disease with portal hypertension","volume":"74","author":"Elkrief","year":"2021","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib101","first-page":"855","article-title":"Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension","volume":"44","author":"Seijo","year":"2012","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib102","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib103","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiol.2411051102","article-title":"Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation","volume":"241","author":"Vilgrain","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib104","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1148\/radiol.12111046","article-title":"Liver and spleen stiffness in patients with extrahepatic portal vein obstruction","volume":"263","author":"Sharma","year":"2012","journal-title":"Radiology"},{"issue":"23","key":"10.1016\/j.jhep.2025.08.001_bib105","first-page":"112","article-title":"Application of ultrasonography-elastography score to suspect porto-sinusoidal vascular disease in patients with portal vein thrombosis","volume":"S1499\u20133872","author":"Gioia","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int HBPD INT"},{"key":"10.1016\/j.jhep.2025.08.001_bib106","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","article-title":"Porto-sinusoidal vascular disorder","volume":"77","author":"De Gottardi","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib107","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2024.07.035","article-title":"Porto-sinusoidal vascular liver disorder with portal hypertension: natural history and long-term outcome","volume":"82","author":"Magaz","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib108","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrgastro.2013.258","article-title":"Imaging in clinical decision-making for portal vein thrombosis","volume":"11","author":"Berzigotti","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib109","first-page":"1314","article-title":"Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis","volume":"34","author":"Elkrief","year":"2014","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.21126","article-title":"Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy","volume":"43","author":"M\u00ednguez","year":"2006","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib111","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bjs.6319","article-title":"Epidemiology, risk and prognostic factors in mesenteric venous thrombosis","volume":"95","author":"Acosta","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib112","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/apt.15479","article-title":"A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia","volume":"50","author":"Benmassaoud","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib113","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","article-title":"Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis","volume":"16","author":"Hollingshead","year":"2005","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"10.1016\/j.jhep.2025.08.001_bib114","first-page":"1367","article-title":"Interventional therapy for symptomatic-benign portal vein occlusion","volume":"57","author":"Liu","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/apt.15811","article-title":"A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment","volume":"52","author":"R\u00f6ssle","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib116","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.28466","article-title":"Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis","volume":"63","author":"Noronha Ferreira","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib117","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.2020006827","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"137","author":"Valeriani","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2025.08.001_bib118","first-page":"80","article-title":"Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up","volume":"5","author":"Orr","year":"2007","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jhep.2025.08.001_bib119","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","article-title":"Prognostic factors in noncirrhotic patients with splanchnic vein thromboses","volume":"102","author":"Amitrano","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.12121","article-title":"Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding","volume":"11","author":"Spaander","year":"2013","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.jhep.2025.08.001_bib121","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2024.04.016","article-title":"Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors","volume":"81","author":"Ollivier-Hourmand","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib122","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2022.08.023","article-title":"Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis","volume":"78","author":"Baiges","year":"2023","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2025.08.001_bib123","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200104","article-title":"Rivaroxaban prophylaxis in noncirrhotic portal vein thrombosis","volume":"1","author":"Plessier","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jhep.2025.08.001_bib124","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10620-011-1975-5","article-title":"Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients","volume":"57","author":"Qi","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2025.08.001_bib125","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.28429","article-title":"Noncirrhotic complete obliterative portal vein thrombosis: novel management using trans-splenic transjugular intrahepatic portosystemic shunt with portal vein recanalization","volume":"63","author":"Kallini","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib126","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0043-121348","article-title":"Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis","volume":"56","author":"Klinger","year":"2018","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib127","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.diii.2018.07.009","article-title":"Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion","volume":"100","author":"Marot","year":"2019","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.jhep.2025.08.001_bib128","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/hep.31915","article-title":"TIPS for adults without cirrhosis with chronic mesenteric venous thrombosis and EHPVO refractory to standard-of-care therapy","volume":"74","author":"Knight","year":"2021","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib129","article-title":"Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction","volume":"4","author":"Artru","year":"2022","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jvir.2022.10.039","article-title":"Portal vein recanalization for noncirrhotic portal vein cavernous transformation: transjugular intrahepatic portosystemic shunt creation versus portal vein stent placement","volume":"34","author":"Wei","year":"2023","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"10.1016\/j.jhep.2025.08.001_bib131","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1097\/HEP.0000000000000038","article-title":"Letter to the editor: discussing the place of TIPS in noncirrhotic patients with chronic extrahepatic portal vein occlusion (EHPVO)","volume":"77","author":"Artru","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib132","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/HEP.0000000000000901","article-title":"Abdominal surgery in patients with chronic noncirrhotic extrahepatic portal vein obstruction: a multicenter retrospective study","volume":"81","author":"Elkrief","year":"2025","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib133","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/jhep.2003.50232","article-title":"Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study","volume":"37","author":"Condat","year":"2003","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib134","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jceh.2013.05.015","article-title":"Pathogenesis of portal cavernoma cholangiopathy: is it compression by collaterals or ischemic injury to bile ducts during portal vein thrombosis?","volume":"4","author":"Puri","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib135","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/gut.2006.103606","article-title":"Portal hypertensive biliopathy","volume":"56","author":"Dhiman","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.08.001_bib136","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/gut.2010.230201","article-title":"Portal cholangiopathy: radiological classification and natural history","volume":"60","author":"Llop","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.08.001_bib137","doi-asserted-by":"crossref","first-page":"298","DOI":"10.14701\/ahbps.22-029","article-title":"Portal cavernoma cholangiopathy: update and recommendations on diagnosis and management","volume":"26","author":"Bhavsar","year":"2022","journal-title":"Ann Hepato-biliary-pancreat Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib138","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0b013e318070cada","article-title":"Therapeutic strategies in symptomatic portal biliopathy","volume":"246","author":"Vibert","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib139","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jamcollsurg.2012.09.013","article-title":"Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children","volume":"216","author":"Lautz","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib140","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/hep.28153","article-title":"Primary prophylaxis of variceal bleeding in children and the role of MesoRex bypass: summary of the Baveno VI pediatric satellite symposium","volume":"63","author":"Shneider","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib141","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/MPG.0000000000002643","article-title":"Long-term outcomes and health perceptions in pediatric-onset portal hypertension complicated by varices","volume":"70","author":"Luoto","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2025.08.001_bib142","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1089\/lap.2022.0404","article-title":"Surgical treatment of portal hypertension in children","volume":"33","author":"Alkhasov","year":"2023","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"10.1016\/j.jhep.2025.08.001_bib143","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jpedsurg.2019.01.035","article-title":"Cystic fibrosis and portal hypertension: distal splenorenal shunt can prevent the need for future liver transplant","volume":"54","author":"Lemoine","year":"2019","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib144","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MPG.0000000000002206","article-title":"Recanalization of chronic extrahepatic portal vein obstruction in pediatric patients using a minilaparotomy approach","volume":"68","author":"Muratore","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.jhep.2025.08.001_bib145","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1007\/s00330-024-11040-8","article-title":"Percutaneous recanalization of non-cirrhotic extrahepatic portal vein obstruction in children: technical considerations in a preliminary cohort","volume":"35","author":"Marra","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib146","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13001","article-title":"Increased risk of portal vein thrombosis in patients with autoimmune hepatitis on the liver transplantation waiting list","volume":"31","author":"Ruiz","year":"2017","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib147","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11239-023-02912-9","article-title":"Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies","volume":"57","author":"Stupia","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jhep.2025.08.001_bib148","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-230X-12-114","article-title":"Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients","volume":"12","author":"Ayala","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib149","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib150","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MEG.0000000000000325","article-title":"De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system","volume":"27","author":"Abdel-Razik","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib151","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5152\/tjg.2022.211022","article-title":"Metabolic disorders and risk of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"33","author":"Li","year":"2022","journal-title":"Turk J Gastroenterol Off J Turk Soc Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib152","first-page":"185","article-title":"Portal vein thrombosis after hepatitis C eradication with direct acting antiviral therapy","volume":"38","author":"Stine","year":"2018","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib153","first-page":"2954","article-title":"Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response","volume":"41","author":"Mandorfer","year":"2021","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib154","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ueg2.12496","article-title":"Predicting de-novo portal vein thrombosis after HCV eradication: a long-term competing risk analysis in the ongoing PITER cohort","volume":"12","author":"Kondili","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhep.2025.08.001_bib155","first-page":"1459","article-title":"Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study","volume":"39","author":"Noronha Ferreira","year":"2019","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib156","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/ajg.2012.313","article-title":"The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors","volume":"107","author":"Amitrano","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib157","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/MCG.0b013e318254e9d4","article-title":"Hypoxic hepatitis occurring in cirrhosis after variceal bleeding: still a lethal disease","volume":"46","author":"Amitrano","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib158","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D\u2019Amico","year":"2003","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib159","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s12072-023-10493-1","article-title":"Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study","volume":"17","author":"Lv","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2025.08.001_bib160","first-page":"2564","article-title":"Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation","volume":"18","author":"Zhang","year":"2020","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jhep.2025.08.001_bib161","first-page":"1318","article-title":"Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis","volume":"31","author":"Zanetto","year":"2018","journal-title":"Transpl Int Off J Eur Soc Organ Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib162","first-page":"207","article-title":"Distinguishing tumor from bland portal vein thrombus in liver transplant candidates with hepatocellular carcinoma: the A-VENA criteria","volume":"25","author":"Sherman","year":"2019","journal-title":"Liver Transpl Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc"},{"key":"10.1016\/j.jhep.2025.08.001_bib163","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2023.02.023","article-title":"Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: the IMPORTAL competing-risk meta-analysis","volume":"79","author":"Guerrero","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.06.035","article-title":"Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study.","author":"Puente","year":"2025","journal-title":"J Hepatol."},{"key":"10.1016\/j.jhep.2025.08.001_bib165","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib166","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib167","first-page":"919","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib168","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1538-7836.2012.04824.x","article-title":"Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis","volume":"10","author":"Senzolo","year":"2012","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.jhep.2025.08.001_bib169","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MEG.0000000000001237","article-title":"A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis","volume":"31","author":"Rodriguez-Castro","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib170","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.amjmed.2021.05.013","article-title":"Comparison of fondaparinux and low-molecular-weight heparin in the treatment of portal vein thrombosis in cirrhosis","volume":"134","author":"Senzolo","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib171","first-page":"776","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jhep.2025.08.001_bib172","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib173","first-page":"820","article-title":"Optimal length of anticoagulant therapy in cirrhotic patients with portal vein thrombosis","volume":"10","author":"Rodr\u00edguez-Castro","year":"2012","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"4","key":"10.1016\/j.jhep.2025.08.001_bib174","article-title":"Safety of anticoagulation when undergoing endoscopic variceal ligation: a systematic review and meta-analysis","volume":"45","author":"Loo","year":"2025","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib175","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s12072-021-10233-3","article-title":"A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?","volume":"15","author":"Dong","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2025.08.001_bib176","article-title":"Usage of direct acting oral anticoagulants in cirrhotic and non-cirrhotic portal vein thrombosis: a systematic review","volume":"13","author":"Gupta","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jhep.2025.08.001_bib177","first-page":"56","article-title":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"54","author":"Koh","year":"2022","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib178","first-page":"2110","article-title":"Bleeding and thrombotic complications in patients with cirrhosis: a state-of-the-Art Appraisal","volume":"21","author":"Rautou","year":"2023","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jhep.2025.08.001_bib179","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s12072-021-10247-x","article-title":"A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis","volume":"15","author":"Ng","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2025.08.001_bib180","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/qjmed\/hcz127","article-title":"Safety of direct oral anticoagulants in patients with cirrhosis: a systematic review and meta-analysis","volume":"112","author":"Lapumnuaypol","year":"2019","journal-title":"QJM Mon J Assoc Physicians"},{"key":"10.1016\/j.jhep.2025.08.001_bib181","article-title":"Direct oral anticoagulants in cirrhosis: rationale and current evidence","volume":"6","author":"Pereira","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib182","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2036.2006.02820.x","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation","volume":"23","author":"Senzolo","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib183","article-title":"TIPS placement via combined transjugular and transhepatic approach for cavernous portal vein occlusion: targeted approach","volume":"2013","author":"Jourabchi","year":"2013","journal-title":"Case Rep Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib184","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.tvir.2016.01.006","article-title":"Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations","volume":"19","author":"Thornburg","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib185","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00270-020-02713-0","article-title":"Percutaneous ultrasound-guided superior and inferior mesenteric vein access for portal vein recanalization-transjugular intrahepatic portosystemic shunt: a case series","volume":"44","author":"Entezari","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib186","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.tvir.2016.01.005","article-title":"Thrombolysis and transjugular intrahepatic portosystemic shunt creation for acute and subacute portal vein thrombosis","volume":"19","author":"Chamarthy","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib187","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","volume":"49","author":"Rodrigues","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib188","article-title":"Anticoagulation and transjugular intrahepatic portosystemic shunting for treatment of portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"25","author":"Davis","year":"2019","journal-title":"Clin Appl Thromb Off J Int Acad Clin Appl Thromb"},{"key":"10.1016\/j.jhep.2025.08.001_bib189","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1148\/radiol.15141252","article-title":"Advanced cirrhosis combined with portal vein thrombosis: a randomized trial of TIPS versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding","volume":"276","author":"Luo","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib190","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","article-title":"Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial","volume":"67","author":"Lv","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.08.001_bib191","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1080\/00365521.2022.2094724","article-title":"Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis","volume":"57","author":"Wu","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib192","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2023.01.007","article-title":"Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis","volume":"78","author":"Fundora","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib193","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/jcm11030800","article-title":"The pathophysiology of portal vein thrombosis in cirrhosis: getting deeper into Virchow\u2019s triad","volume":"11","author":"Anton","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib194","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1148\/radiol.2015150369","article-title":"Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial","volume":"279","author":"Wang","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib195","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/TP.0b013e31826e8e53","article-title":"Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review","volume":"94","author":"Rodr\u00edguez-Castro","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2025.08.001_bib196","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1111\/jth.15472","article-title":"Therapeutic anticoagulation after liver transplantation is not useful among patients with pre-transplant Yerdel-grade I\/II portal vein thrombosis: a two-center retrospective study","volume":"19","author":"Bos","year":"2021","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.jhep.2025.08.001_bib197","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transproceed.2018.07.014","article-title":"Utility of oral anticoagulants as prophylaxis of recurrent portal thrombosis after liver transplantation","volume":"51","author":"Sanchez-Oca\u00f1a","year":"2019","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2025.08.001_bib198","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/TP.0000000000003235","article-title":"The impact of portal vein thrombosis on liver transplant outcomes: does grade or flow rate matter?","volume":"105","author":"Rizzari","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2025.08.001_bib199","article-title":"Porto-sinusoidal vascular disorder in chronic HBV: a significant coexistence not to be overlooked","volume":"6","author":"Olivas","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1440-1746.2002.02596.x","article-title":"Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature","volume":"17","author":"Dhiman","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib201","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.08.001_bib202","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1365-2036.2012.05112.x","article-title":"Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study","volume":"35","author":"Schouten","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib203","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00535-012-0703-z","article-title":"Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography","volume":"48","author":"Furuichi","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib204","first-page":"75","article-title":"Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension","volume":"55","author":"Ferreira-Silva","year":"2023","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib205","first-page":"189","article-title":"Computed tomography during arterial portography in idiopathic portal hypertension","volume":"2","author":"Matsui","year":"1984","journal-title":"Radiat Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib206","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.0106-9543.2002.01663.x","article-title":"Heterogeneous hepatic enhancement on CT angiography in idiopathic portal hypertension","volume":"22","author":"Waguri","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib207","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00330-022-09132-4","article-title":"Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder","volume":"33","author":"Lampichler","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib208","doi-asserted-by":"crossref","first-page":"S719","DOI":"10.1016\/S0168-8278(24)02032-4","article-title":"WED-177 Determination of liver biopsy quality criteria for the diagnosis of porto-sinusoidal vascular disorder (PSVD)","volume":"80","author":"De Broucker","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib209","first-page":"454","article-title":"Obliterative portal venopathy without portal hypertension: an underestimated condition","volume":"36","author":"Guido","year":"2016","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib210","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MIB.0000000000001036","article-title":"Nodular regenerative hyperplasia of the liver in patients with IBD treated with allopurinol-thiopurine combination therapy","volume":"23","author":"Seinen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2025.08.001_bib211","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/hep.1840100534","article-title":"Idiopathic portal hypertension and protein C deficiency","volume":"10","author":"Okuda","year":"1989","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib212","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212157","article-title":"Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: a systematic review","volume":"14","author":"Toksvang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2025.08.001_bib213","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/hep.30132","article-title":"Idiopathic portal hypertension","volume":"68","author":"Hern\u00e1ndez-Gea","year":"2018","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib214","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep.32735","article-title":"Genetic predisposition to porto-sinusoidal vascular disorder: a functional genomic-based, multigenerational family study","volume":"77","author":"Shan","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib215","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/hep.28499","article-title":"Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension","volume":"63","author":"Vilarinho","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib216","first-page":"1130","article-title":"Familial aggregation in noncirrhotic portal fibrosis: a report of four families","volume":"82","author":"Sarin","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib217","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jhep.2015.11.027","article-title":"A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension","volume":"64","author":"Koot","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib218","article-title":"Genetic predisposition to porto-sinusoidal vascular disorder","author":"Ciriaci","year":"2024","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib219","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00535-023-01957-0","article-title":"Portal vein thrombosis, hepatic decompensation, and survival in patients with porto-sinusoidal vascular disease and portal hypertension","volume":"58","author":"Zhang","year":"2023","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib220","article-title":"Progression of hepatic adenoma to carcinoma in the setting of hepatoportal sclerosis in HIV patient: case report and review of the literature","volume":"2016","author":"Montenovo","year":"2016","journal-title":"Case Rep Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib221","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0016-5085(89)91427-3","article-title":"Hepatocellular carcinoma without cirrhosis in Japanese patients","volume":"97","author":"Okuda","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib222","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0000000000004444","article-title":"Liver transplantation for porto-sinusoidal vascular liver disorder: long-term outcome","volume":"107","author":"Magaz","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2025.08.001_bib223","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jhep.2010.07.038","article-title":"Obliterative portal venopathy: portal hypertension is not always present at diagnosis","volume":"54","author":"Cazals-Hatem","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib224","first-page":"978","article-title":"Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan","volume":"25","author":"Matsutani","year":"2005","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1440-1746.2006.04492.x","article-title":"Pathological study of idiopathic portal hypertension with an emphasis on cause of death based on records of Annuals of Pathological Autopsy Cases in Japan","volume":"22","author":"Sawada","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib226","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2002-23207","article-title":"Idiopathic portal hypertension and its pathology","volume":"22","author":"Okudaira","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2025.08.001_bib227","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00005792-197401000-00003","article-title":"\u201cIdiopathic\u201d portal hypertension due to occlusion of intrahepatic portal veins by organized thrombi. A study based on postmortem vinylite-injection corrosion and dissection of the intrahepatic vasculature in 4 cases","volume":"53","author":"Boyer","year":"1974","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2025.08.001_bib228","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.28547","article-title":"Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension","volume":"64","author":"Bissonnette","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib229","first-page":"929","article-title":"Liver transplantation for the treatment of nodular regenerative hyperplasia","volume":"43","author":"Manzia","year":"2011","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib230","first-page":"627","article-title":"Liver transplantation for severe intrahepatic noncirrhotic portal hypertension","volume":"11","author":"Krasinskas","year":"2005","journal-title":"Liver Transpl Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc"},{"key":"10.1016\/j.jhep.2025.08.001_bib231","first-page":"358","article-title":"Mutations in the novel gene FOPV are associated with familial autosomal dominant and non-familial obliterative portal venopathy","volume":"38","author":"Besmond","year":"2018","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib232","first-page":"1523","article-title":"Paediatric porto-sinusoidal vascular disease: two different clinical phenotypes with subtle histological differences","volume":"43","author":"Di Giorgio","year":"2023","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib233","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1097\/MPG.0000000000003445","article-title":"Porto-sinusoidal vascular disease: a pediatric study of 30 patients","volume":"74","author":"Girard","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2025.08.001_bib234","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/hep.27747","article-title":"The significance of nonobstructive sinusoidal dilatation of the liver: impaired portal perfusion or inflammatory reaction syndrome","volume":"62","author":"Marzano","year":"2015","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-018-2331-3","article-title":"Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts","volume":"473","author":"Valla","year":"2018","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.jhep.2025.08.001_bib236","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0016-5085(78)90853-3","article-title":"Incidence and clinical significance of sinusoidal dilatation in liver biopsies","volume":"75","author":"Bruguera","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib237","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.forsciint.2004.05.010","article-title":"Pathology of peliosis","volume":"149","author":"Tsokos","year":"2005","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jhep.2025.08.001_bib238","doi-asserted-by":"crossref","first-page":"13188","DOI":"10.3748\/wjg.v21.i46.13188","article-title":"Peliosis hepatis: personal experience and literature review","volume":"21","author":"Crocetti","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib239","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s002610000131","article-title":"Peliosis hepatis with pseudotumoral and hemorrhagic evolution: CT and MR findings","volume":"26","author":"Ferrozzi","year":"2001","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jhep.2025.08.001_bib240","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2214\/ajr.183.4.1831075","article-title":"Imaging findings of hepatic sinusoidal dilatation","volume":"183","author":"Yang","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2025.08.001_bib241","article-title":"Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver","volume":"26","author":"M","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib242","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00261-018-1465-8","article-title":"Hepatic sinusoidal dilatation","volume":"43","author":"Brancatelli","year":"2018","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.jhep.2025.08.001_bib243","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1007\/s00261-019-02057-5","article-title":"The \u201cmosaic pattern\u201d in hepatic sinusoidal dilatation","volume":"44","author":"Mamone","year":"2019","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.jhep.2025.08.001_bib244","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jgf2.501","article-title":"Constrictive pericarditis 20 years after surgical aortic valve replacement","volume":"23","author":"Nishizawa","year":"2022","journal-title":"J Gen Fam Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib245","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jhep.2023.11.027","article-title":"Hepatomegaly in a patient with a history of acute myeloid leukemia","volume":"80","author":"Moga","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib246","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4254\/wjh.v10.i5.417","article-title":"Isolated hepatic non-obstructive sinusoidal dilatation, 20-year single center experience","volume":"10","author":"Sunjaya","year":"2018","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib247","first-page":"248","article-title":"Hepatic sinusoidal dilatation related to oral contraceptives. A study of two patients showing ultrastructural changes","volume":"72","author":"Spellberg","year":"1979","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib248","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0016-5085(81)90145-1","article-title":"Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill","volume":"80","author":"Camilleri","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib249","first-page":"e10","article-title":"Oral contraceptive-induced hepatic sinusoidal dilatation","volume":"47","author":"Kumar","year":"2015","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib250","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0232-1513(88)80092-6","article-title":"Sinusoidal dilatation of the liver in patients on oral contraceptives. Electron microscopical study of 14 cases","volume":"35","author":"Bal\u00e1zs","year":"1988","journal-title":"Exp Pathol"},{"key":"10.1016\/j.jhep.2025.08.001_bib251","doi-asserted-by":"crossref","first-page":"901","DOI":"10.5858\/2004-128-901-SDACIL","article-title":"Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment?","volume":"128","author":"Kakar","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib252","first-page":"782","article-title":"Effect of preoperative chemotherapy on liver resection for colorectal liver metastases","volume":"34","author":"Mehta","year":"2008","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.jhep.2025.08.001_bib253","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jhep.2025.08.001_bib254","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jhep.2025.08.001_bib255","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/314868","article-title":"A reappraisal of chemotherapy-induced liver injury in colorectal liver metastases before the Era of Antiangiogenics","volume":"2013","author":"Nguyen-Khac","year":"2013","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib256","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0168-8278(85)80771-6","article-title":"Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation","volume":"1","author":"Gerlag","year":"1985","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib257","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1136\/ard.2003.017855","article-title":"Sinusoidal dilatation: a rare side effect of azathioprine","volume":"63","author":"Jacobi","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jhep.2025.08.001_bib258","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/00365521.1975.12097034","article-title":"Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids","volume":"10","author":"Winkler","year":"1975","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib259","first-page":"722","article-title":"Oral contraceptive-induced hepatic sinusoidal dilatation and potential implications for living donor liver transplantation: a reason for Nonuse of right lobe grafts","volume":"26","author":"Stotts","year":"2020","journal-title":"Liver Transpl Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc"},{"key":"10.1016\/j.jhep.2025.08.001_bib260","series-title":"LiverTox: Clinical and research Information on drug-induced liver injury. Bethesda (MD): National Institute of diabetes and Digestive and kidney diseases","article-title":"Estrogens and oral contraceptives","author":"Anon","year":"2012"},{"key":"10.1016\/j.jhep.2025.08.001_bib261","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/his.12114","article-title":"Histological features in western patients with idiopathic non-cirrhotic portal hypertension","volume":"62","author":"Verheij","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.jhep.2025.08.001_bib262","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1111\/j.1440-1746.2007.05156.x","article-title":"Congenital veno-venous malformations of the liver: widely variable clinical presentations","volume":"23","author":"Witters","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib263","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/gut.2003.037135","article-title":"Association of idiopathic hepatic sinusoidal dilatation with the immunological features of the antiphospholipid syndrome","volume":"53","author":"Saadoun","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.08.001_bib264","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archinte.1985.00360050197037","article-title":"Ultrasonography in the diagnosis and follow-up of hepatic sinusoidal dilatation","volume":"145","author":"Weinberger","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib265","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jmri.28673","article-title":"MRI of peliosis hepatis: a case series presentation with a 2022 systematic literature update","volume":"58","author":"Calistri","year":"2023","journal-title":"J Magn Reson Imaging JMRI"},{"key":"10.1016\/j.jhep.2025.08.001_bib266","doi-asserted-by":"crossref","first-page":"W43","DOI":"10.2214\/AJR.05.0167","article-title":"Peliosis hepatis: spectrum of imaging findings","volume":"187","author":"Iannaccone","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2025.08.001_bib267","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s40792-023-01774-w","article-title":"A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer","volume":"9","author":"Dejima","year":"2023","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.jhep.2025.08.001_bib268","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.radcr.2023.02.047","article-title":"Solitary peliosis hepatis mimics a liver metastasis on contrast-enhanced ultrasound","volume":"18","author":"Spiesecke","year":"2023","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.jhep.2025.08.001_bib269","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.3748\/wjg.v20.i9.2420","article-title":"Peliosis hepatis complicated by portal hypertension following renal transplantation","volume":"20","author":"Yu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib270","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.5858\/2004-128-1283-PHAWLL","article-title":"Peliosis hepatis associated with lymphoplasmacytic lymphoma: an autopsy case report","volume":"128","author":"Corpa","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib271","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1634\/theoncologist.2009-0215","article-title":"First reported case of disease: peliosis hepatis as cardinal symptom of Hodgkin\u2019s lymphoma","volume":"14","author":"Kleger","year":"2009","journal-title":"The Oncologist"},{"key":"10.1016\/j.jhep.2025.08.001_bib272","series-title":"StatPearls. Treasure Island (FL)","article-title":"Bacillary angiomatosis","author":"Akram","year":"2023"},{"key":"10.1016\/j.jhep.2025.08.001_bib273","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/j.1536-4801.2004.tb00880.x","article-title":"Peliosis hepatis in childhood: case report and review of the literature","volume":"39","author":"Samyn","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2025.08.001_bib274","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1111\/ajt.15978","article-title":"Living-donor liver transplantation for liver hemorrhaging due to peliosis hepatis in X-linked myotubular myopathy: two cases and a literature review","volume":"20","author":"Shimizu","year":"2020","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib275","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0168-8278(99)80271-2","article-title":"Peliosis hepatis with initial presentation as acute hepatic failure and intraperitoneal hemorrhage in children","volume":"30","author":"Jacquemin","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib276","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)","volume":"58","author":"Mohty","year":"2023","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib277","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41409-023-02077-2","article-title":"Current incidence, severity, and management of veno-occlusive disease\/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study","volume":"58","author":"Ruutu","year":"2023","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib278","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1055\/s-0035-1556728","article-title":"Interplay of inflammation and endothelial dysfunction in bone marrow transplantation: focus on hepatic veno-occlusive disease","volume":"41","author":"Vion","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jhep.2025.08.001_bib279","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib280","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jhep.2025.08.001_bib281","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2025.08.001_bib282","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib283","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009311.pub2","article-title":"Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation","author":"Cheuk","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2025.08.001_bib284","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jhep.2025.08.001_bib285","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40261-022-01140-y","article-title":"A systematic review and meta-analysis of studies of defibrotide prophylaxis for veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"42","author":"Corbacioglu","year":"2022","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jhep.2025.08.001_bib286","first-page":"765.e1","article-title":"Defibrotide shows efficacy in the prevention of sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: a retrospective study","volume":"28","author":"Chalandon","year":"2022","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib287","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S2352-3026(23)00011-X","article-title":"Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial","volume":"10","author":"Grupp","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jhep.2025.08.001_bib288","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.hemonc.2021.09.002","article-title":"Efficacy and safety of recombinant thrombomodulin for the prophylaxis of veno-occlusive complication in allogeneiccit hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"16","author":"Kashyap","year":"2023","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib289","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","article-title":"Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"37","author":"Imran","year":"2006","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib290","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.3390\/jcm13226917","article-title":"Hepatic sinusoidal obstruction syndrome\/veno-occlusive disease (SOS\/VOD) primary prophylaxis in patients undergoing hematopoietic stem cell transplantation: a network meta-analysis of randomized controlled trials","volume":"13","author":"Sousa-Pimenta","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhep.2025.08.001_bib291","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111526","article-title":"Review of imaging findings in hepatic veno-occlusive disease","volume":"177","author":"Simpson","year":"2024","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib292","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1148\/radiol.10100025","article-title":"Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation","volume":"258","author":"Mahgerefteh","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib293","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1148\/radiology.204.2.9240551","article-title":"Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients","volume":"204","author":"Lassau","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib294","article-title":"Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease","volume":"154","author":"Bp","year":"1990","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2025.08.001_bib295","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3324\/haematol.2019.245407","article-title":"Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation","volume":"106","author":"Debureaux","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jhep.2025.08.001_bib296","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12185-021-03137-3","article-title":"Refined ultrasonographic criteria for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation","volume":"114","author":"Nishida","year":"2021","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jhep.2025.08.001_bib297","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.bbmt.2018.05.025","article-title":"Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation","volume":"24","author":"Nishida","year":"2018","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib298","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbmt.2019.01.019","article-title":"Liver stiffness measurement allows early diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome in adult patients who undergo hematopoietic stem cell transplantation: results from a monocentric prospective study","volume":"25","author":"Colecchia","year":"2019","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"issue":"7","key":"10.1016\/j.jhep.2025.08.001_bib299","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41409-025-02570-w","volume":"60","author":"Ravaioli","year":"2025","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib300","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2025.08.001_bib301","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib302","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Rj","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2025.08.001_bib303","article-title":"Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions","volume":"4","author":"Gressens","year":"2022","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib304","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00270-013-0672-5","article-title":"Diagnostic yield of transjugular liver biopsy samples to evaluate for infectious etiology of liver dysfunction in bone marrow transplant recipients","volume":"37","author":"Nadolski","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib305","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2025.08.001_bib306","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjh.15267","article-title":"Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"181","author":"Kernan","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2025.08.001_bib307","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.510240321","article-title":"Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation","volume":"24","author":"Fried","year":"1996","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib308","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1702386","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation","volume":"25","author":"Azoulay","year":"2000","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib309","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","author":"European Association for the Study of the Liver","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib311","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.bbmt.2020.08.006","article-title":"Transjugular intrahepatic portosystemic shunt for very severe veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) after unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide","volume":"26","author":"G\u00f3mez-Centuri\u00f3n","year":"2020","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib312","doi-asserted-by":"crossref","DOI":"10.1097\/PG9.0000000000000355","article-title":"Successful transjugular portosystemic shunt treatment of pediatric sinusoidal obstruction: case report and review of literature","volume":"4","author":"Ramic","year":"2023","journal-title":"JPGN Rep"},{"key":"10.1016\/j.jhep.2025.08.001_bib313","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/hep.20773","article-title":"TIPS for veno-occlusive disease: is the contraindication real?","volume":"42","author":"Senzolo","year":"2005","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib314","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1034\/j.1600-6143.2002.20815.x","article-title":"A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation","volume":"2","author":"Kim","year":"2002","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1399-0012.2008.00814.x","article-title":"Liver transplantation for sinusoidal obstructive syndrome (veno-occlusive disease): case report with review of the literature and the UNOS database","volume":"22","author":"Membreno","year":"2008","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib316","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41409-018-0255-9","article-title":"Solid organ transplantation following allogeneic haematopoietic cell transplantation: experience from a referral organ transplantation center and systematic review of literature","volume":"54","author":"Brockmann","year":"2019","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib317","series-title":"Long-term outcome of sinusoidal obstruction syndrome secondary to hematopoietic stem cell transplantation","author":"Alvarado-Tapias Edilmar","year":"2025"},{"key":"10.1016\/j.jhep.2025.08.001_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36883","article-title":"Burden of illness of non-hematopoietic stem cell transplant-related hepatic sinusoidal obstruction syndrome: a systematic review","volume":"10","author":"Fan","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jhep.2025.08.001_bib319","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.jhep.2025.08.001_bib320","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/SLA.0b013e3181c79403","article-title":"Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome","volume":"251","author":"Soubrane","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib321","first-page":"1721","article-title":"Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure","volume":"56","author":"Puente","year":"2024","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib322","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1148\/radiol.2015141749","article-title":"Hepatic parenchymal heterogeneity on contrast-enhanced CT scans following oxaliplatin-based chemotherapy: natural history and association with clinical evidence of sinusoidal obstruction syndrome","volume":"276","author":"Han","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib323","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","article-title":"Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury","volume":"28","author":"Overman","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jhep.2025.08.001_bib324","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib325","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1245\/s10434-012-2438-8","article-title":"Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis","volume":"19","author":"Robinson","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhep.2025.08.001_bib326","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152882","article-title":"Oxaliplatin-induced hepatic sinusoidal obstruction syndrome","volume":"460","author":"Zhu","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.jhep.2025.08.001_bib327","first-page":"225","article-title":"Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury","volume":"8","author":"Slade","year":"2009","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.jhep.2025.08.001_bib328","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.10.011","article-title":"Long-term sequelae of drug-induced liver injury","volume":"76","author":"Bj\u00f6rnsson","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib329","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210352","article-title":"Long-term follow-up of oxaliplatin-induced liver damage in patients with colorectal cancer","volume":"94","author":"Cha","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib330","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/hep.30984","article-title":"Post-liver transplantation sinusoidal obstruction syndrome with refractory ascites induced by mycophenolate mofetil","volume":"71","author":"Poli","year":"2020","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib331","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.12998\/wjcc.v10.i36.13408","article-title":"Hepatic sinusoidal obstruction syndrome induced by tacrolimus following liver transplantation: three case reports","volume":"10","author":"Jiang","year":"2022","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jhep.2025.08.001_bib332","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajpath.2019.02.007","article-title":"Understanding the similarities and differences between hepatic and pulmonary veno-occlusive disease","volume":"189","author":"G\u00fcnther","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2025.08.001_bib333","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jgh.14612","article-title":"Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome","volume":"34","author":"Zhuge","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib334","article-title":"Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: a multicenter retrospective study","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jhep.2025.08.001_bib335","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MEG.0000000000002509","article-title":"Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome","volume":"35","author":"Huang","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib336","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.3748\/wjg.v26.i24.3472","article-title":"Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome","volume":"26","author":"Zhou","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib337","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib338","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31331","article-title":"Early defibrotide therapy and risk factors for post-transplant veno-occlusive disease\/sinusoidal obstruction syndrome in childhood","volume":"71","author":"Goto","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jhep.2025.08.001_bib339","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","article-title":"Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients","volume":"32","author":"Barker","year":"2003","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib340","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"90","author":"Cesaro","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jhep.2025.08.001_bib341","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib342","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00277-019-03604-2","article-title":"The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan","volume":"98","author":"Lee","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jhep.2025.08.001_bib343","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2352-3026(19)30201-7","article-title":"Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement","volume":"7","author":"Mahadeo","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jhep.2025.08.001_bib344","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bbmt.2016.07.011","article-title":"High variability in the reported management of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"22","author":"Skeens","year":"2016","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib345","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jvs.2019.02.024","article-title":"A systematic review and meta-analysis of the management of visceral artery aneurysms","volume":"70","author":"Barrionuevo","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib346","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2020.01.039","article-title":"The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms","volume":"72","author":"Chaer","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib347","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jvs.2006.10.049","article-title":"The endovascular management of visceral artery aneurysms and pseudoaneurysms","volume":"45","author":"Tulsyan","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib348","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.diii.2015.06.014","article-title":"Arterial splanchnic aneurysms: presentation, treatment and outcome in 112 patients","volume":"97","author":"T\u00e9treau","year":"2016","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.jhep.2025.08.001_bib349","first-page":"488","article-title":"The multidetector computed tomography angiography (MDCTA) in the diagnosis of splenic artery aneurysm and pseudoaneurysm","volume":"52","author":"Saba","year":"1987","journal-title":"Acta Radiol Stockh Swed"},{"key":"10.1016\/j.jhep.2025.08.001_bib350","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF02000601","article-title":"Uncommon splanchnic artery aneurysms: pancreaticoduodenal, gastroduodenal, superior mesenteric, inferior mesenteric, and colic","volume":"10","author":"Shanley","year":"1996","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib351","article-title":"Review of visceral aneurysms and pseudoaneurysms","volume":"39","author":"M","year":"2015","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jhep.2025.08.001_bib352","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0221-0363(06)73983-X","article-title":"[Magnetic resonance angiography of splanchnic artery aneurysms and pseudoaneurysms]","volume":"87","author":"Pilleul","year":"2006","journal-title":"J Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib353","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00330-015-3599-1","article-title":"Visceral artery aneurysms: incidence, management, and outcome analysis in a tertiary care center over one decade","volume":"25","author":"Pitton","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib354","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0039-6060(96)80009-2","article-title":"Current management of visceral artery aneurysms","volume":"120","author":"Carr","year":"1996","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2025.08.001_bib355","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10016-001-0207-4","article-title":"Splenic artery aneurysms: two decades experience at Mayo clinic","volume":"16","author":"Abbas","year":"2002","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib356","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.avsg.2016.09.018","article-title":"Pancreaticoduodenal and gastroduodenal artery aneurysms associated with celiac artery occlusive disease","volume":"41","author":"Vandy","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib357","first-page":"898","article-title":"Pathogenesis and clinical significance of splenic artery aneurysms","volume":"76","author":"Stanley","year":"1974","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2025.08.001_bib358","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.transproceed.2022.01.031","article-title":"Splenic artery aneurysm management in the cirrhotic patient listed for liver transplantation: a systematic review","volume":"54","author":"Phan","year":"2022","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2025.08.001_bib359","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jvs.2015.10.066","article-title":"The natural history of splanchnic artery aneurysms and outcomes after operative intervention","volume":"63","author":"Corey","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib360","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jvs.2015.01.005","article-title":"Contemporary outcomes of intact and ruptured visceral artery aneurysms","volume":"61","author":"Shukla","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib361","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.avsg.2020.10.047","article-title":"Natural history of splanchnic artery aneurysms","volume":"73","author":"Batagini","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib362","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jvs.2017.12.057","article-title":"Natural history and management of splanchnic artery aneurysms in a single tertiary referral center","volume":"68","author":"Erben","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib363","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejrad.2006.02.004","article-title":"Multimodal approach to endovascular treatment of visceral artery aneurysms and pseudoaneurysms","volume":"59","author":"Lagan\u00e0","year":"2006","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib364","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2214\/ajr.185.3.01850741","article-title":"Visceral and peripheral arterial pseudoaneurysms","volume":"185","author":"Sueyoshi","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2025.08.001_bib365","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jvs.2003.09.049","article-title":"Aneurysm of the pancreaticoduodenal arteries with a celiac trunk lesion: current management","volume":"39","author":"Ducasse","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib366","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/j.tvir.2014.12.003","article-title":"Endovascular management of visceral arterial aneurysms","volume":"18","author":"Hemp","year":"2015","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib367","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00270-008-9343-3","article-title":"Endovascular management of ruptured pancreaticoduodenal artery aneurysms associated with celiac axis stenosis","volume":"31","author":"Suzuki","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib368","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jamcollsurg.2016.10.030","article-title":"Does management of true aneurysms of peripancreatic arteries require repair of associated celiac artery stenosis?","volume":"224","author":"Boll","year":"2017","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib369","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijsu.2007.08.002","article-title":"Splenic artery aneurysms in pregnancy--a systematic review","volume":"6","author":"Sadat","year":"2008","journal-title":"Int J Surg Lond Engl"},{"key":"10.1016\/j.jhep.2025.08.001_bib370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bpg.2016.10.017","article-title":"Visceral aneurysms: old paradigms, new insights?","volume":"31","author":"Rijn","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib371","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.1532\/hsf.1972","article-title":"Surgical resection of thoracic aortic aneurysms in Wiskott-Aldrich syndrome","volume":"21","author":"Onalan","year":"2018","journal-title":"Heart Surg Forum"},{"key":"10.1016\/j.jhep.2025.08.001_bib372","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13352","article-title":"Visceral artery anomalies in patients with Alagille syndrome","volume":"23","author":"Sanada","year":"2019","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib373","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1054-8807(97)00081-1","article-title":"Vasculopathies of Neurofibromatosis Type 1 (von Recklinghausen Disease)","volume":"7","author":"Lie","year":"1998","journal-title":"Cardiovasc Pathol Off J Soc Cardiovasc Pathol"},{"key":"10.1016\/j.jhep.2025.08.001_bib374","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1399-3046.2003.00150.x","article-title":"Fatal and life threatening rupture of splenic artery aneurysms in children with portal hypertension","volume":"8","author":"Evans","year":"2004","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2025.08.001_bib375","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00247-008-0976-9","article-title":"Multidetector CT findings of splenic artery aneurysm in children with chronic liver disease","volume":"38","author":"Ulu","year":"2008","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib376","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/1747493018778713","article-title":"(WSO), Sacks D, Baxter B, et al. Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke","volume":"13","author":"From the American Association of Neurological Surgeons (AANS), American Society of Neuroradiology (ASNR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Canadian Interventional Radiology Association (CIRA)","year":"2018","journal-title":"Int J Stroke Off J Int Stroke Soc"},{"key":"10.1016\/j.jhep.2025.08.001_bib377","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00431-021-04201-0","article-title":"Gastrointestinal bleeding due to pseudoaneurysms in children","volume":"181","author":"Seetharaman","year":"2022","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jhep.2025.08.001_bib378","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/0016-5085(78)90693-5","article-title":"Frequency of intrahepatic arteriovenous fistula as a sequela to percutaneous needle puncture of the liver","volume":"74","author":"Okuda","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib379","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12328-011-0277-y","article-title":"Gastric variceal bleeding caused by an intrahepatic arterioportal fistula that formed after liver biopsy: a case report and review of the literature","volume":"5","author":"Iwaki","year":"2012","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib380","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3748\/wjg.v21.i7.2229","article-title":"Portal hypertension induced by congenital hepatic arterioportal fistula: report of four clinical cases and review of the literature","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib381","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.jpedsurg.2009.07.027","article-title":"Congenital intrahepatic arterioportal fistula presenting as severe undernutrition and chronic watery diarrhea in a 2-year-old girl","volume":"44","author":"Tannuri","year":"2009","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib382","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.mpg.0000221890.13630.ad","article-title":"The congenital intrahepatic arterioportal fistula syndrome: elucidation and proposed classification","volume":"43","author":"Norton","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2025.08.001_bib383","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.gassur.2005.06.022","article-title":"Arterioportal fistulas: introduction of a novel classification with therapeutic implications","volume":"10","author":"Guzman","year":"2006","journal-title":"J Gastrointest Surg Off J Soc Surg Aliment Tract"},{"key":"10.1016\/j.jhep.2025.08.001_bib384","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mri.2020.09.008","article-title":"Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver","volume":"75","author":"Renzulli","year":"2021","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2025.08.001_bib385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3348\/kjr.2002.3.1.1","article-title":"Hepatic arterioportal shunts: dynamic CT and MR features","volume":"3","author":"Choi","year":"2002","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib386","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1148\/radiol.2322030966","article-title":"Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT","volume":"232","author":"Byun","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib387","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2214\/ajr.146.4.723","article-title":"Dynamic CT features of arterioportal shunts in hepatocellular carcinoma","volume":"146","author":"Itai","year":"1986","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2025.08.001_bib388","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1148\/radiol.2262011967","article-title":"Cirrhosis or chronic hepatitis: evaluation of small (<or=2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging","volume":"226","author":"Shimizu","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib389","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/15385744231165155","article-title":"Hepatic arterioportal fistula following liver trauma: case series and review of the literature","volume":"57","author":"Noorbakhsh","year":"2023","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib390","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00004836-200204000-00022","article-title":"Arterioportal fistula causing acute pancreatitis and hemobilia after liver biopsy","volume":"34","author":"Machicao","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib391","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00042737-200106000-00019","article-title":"Pancreatitis and haemobilia due to arterioportal fistula after percutaneous liver biopsy resolved by selective arterial embolization","volume":"13","author":"G\u00f3mez-Valero","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib392","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1538574420954300","article-title":"Arterio-hepatic venous fistula following liver biopsy: a rare case report and literature review","volume":"55","author":"Dutta","year":"2021","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib393","first-page":"1020","article-title":"Arterioportal fistula and hemobilia with associated acute cholecystitis: a complication of percutaneous liver biopsy","volume":"43","author":"Cacho","year":"1996","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib394","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1148\/129.2.315","article-title":"Arteriovenous shunts involving the liver","volume":"129","author":"Adler","year":"1978","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.08.001_bib395","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10140-012-1036-1","article-title":"Imaging of acute conditions affecting the hepatic vasculature","volume":"19","author":"Heller","year":"2012","journal-title":"Emerg Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib396","article-title":"Evaluation of new ultrasound techniques for clinical imaging in selected liver and vascular applications","volume":"65","author":"Brandt","year":"2018","journal-title":"Dan Med J"},{"key":"10.1016\/j.jhep.2025.08.001_bib397","first-page":"504","article-title":"Hepatoportal arteriovenous fistula in primary carcinoma of the liver","volume":"145","author":"Nagasue","year":"1977","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.jhep.2025.08.001_bib398","doi-asserted-by":"crossref","first-page":"620","DOI":"10.14218\/JCTH.2021.00100","article-title":"Hepatic arterioportal fistulas: a retrospective analysis of 97 cases","volume":"10","author":"Cao","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib399","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0009-9260(97)80303-0","article-title":"Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance","volume":"52","author":"Ngan","year":"1997","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib400","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/crad.2000.0477","article-title":"Hepatic arterioportal shunts not directly related to hepatocellular carcinoma: findings on CT during hepatic arteriography, CT arterial portography and dual phase spiral CT","volume":"55","author":"Park","year":"2000","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib401","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2214\/ajr.180.6.1801593","article-title":"Preoperative evaluation of hepatocellular carcinoma: combined use of CT with arterial portography and hepatic arteriography","volume":"180","author":"Kim","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2025.08.001_bib402","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s00330-016-4432-1","article-title":"Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma","volume":"27","author":"Fischer","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2025.08.001_bib403","article-title":"Pre-transarterial radioembolization of tumoral arteriovenous fistula associated with recanalized umbilical vein shunt in a case of hepatocellular carcinoma with hepatic vein and inferior vena cava invasion","volume":"15","author":"Almaguer","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jhep.2025.08.001_bib404","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.1999.00805.x","article-title":"A case report of congenital intrahepatic arterioportal fistula","volume":"94","author":"Alkim","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib405","first-page":"1730","article-title":"Arterio-portal shunt in liver rescued by hepatectomy after arterial embolization","volume":"48","author":"Kobayashi","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib406","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40792-019-0623-8","article-title":"Successful surgical treatment for intrahepatic arterioportal fistula with severe portal hypertension: a case report","volume":"5","author":"Takata","year":"2019","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.jhep.2025.08.001_bib407","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/hepr.12701","article-title":"A successful case of deceased donor liver transplantation for a patient with intrahepatic arterioportal fistula","volume":"46","author":"Takagi","year":"2016","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib408","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1007\/s12325-021-01758-y","article-title":"Patients with congenital low-flow vascular malformation treated with low dose sirolimus","volume":"38","author":"Harbers","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib409","first-page":"183","article-title":"Oral rapamycin: an alternative in children with complicated vascular abnormalities","volume":"33","author":"G\u00f3mez S\u00e1nchez","year":"2020","journal-title":"Cirugia Pediatr Organo Soc Espanola Cirugia Pediatr"},{"key":"10.1016\/j.jhep.2025.08.001_bib410","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jvs.2019.06.217","article-title":"Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review","volume":"71","author":"Freixo","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jhep.2025.08.001_bib411","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000515168","article-title":"Medical adjuvants in the treatment of surgically refractory arteriovenous malformations of the head and face: case report and review of literature","volume":"50","author":"Govindarajan","year":"2021","journal-title":"Cerebrovasc Dis Basel Switz"},{"key":"10.1016\/j.jhep.2025.08.001_bib412","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1172\/JCI127425","article-title":"Correcting Smad1\/5\/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models","volume":"130","author":"Ruiz","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.08.001_bib413","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2010.04.003","article-title":"Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis","volume":"157","author":"Mazereeuw-Hautier","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2025.08.001_bib414","first-page":"414","article-title":"Effectiveness of propranolol in a newborn with liver hemangiomatosis","volume":"20","author":"Meyer","year":"2010","journal-title":"Eur J Pediatr Surg Off J Austrian Assoc Pediatr Surg Al Z Kinderchir"},{"key":"10.1016\/j.jhep.2025.08.001_bib415","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s12098-023-04707-5","article-title":"Propranolol in congenital hepatic arteriovenous malformation","volume":"90","author":"Panda","year":"2023","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jhep.2025.08.001_bib416","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fped.2020.00163","article-title":"Beta blocker therapy for congenital hepatic arteriovenous fistula in two neonates","volume":"8","author":"Ba","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jhep.2025.08.001_bib417","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00383-022-05143-w","article-title":"Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma","volume":"38","author":"Wang","year":"2022","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jhep.2025.08.001_bib418","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000529629","article-title":"Delayed migration of Onyx embolic agent after preoperative embolization of an arteriovenous malformation in a pediatric patient: a case report and review of the literature","volume":"58","author":"Nussbaum","year":"2023","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.jhep.2025.08.001_bib419","first-page":"62","article-title":"New abdominal collaterals at ultrasound: a clue of progression of portal hypertension","volume":"40","author":"Berzigotti","year":"2008","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib420","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jvir.2016.11.091","article-title":"Changes in liver congestion in patients with Budd-chiari syndrome following endovascular interventions: assessment with transient elastography","volume":"28","author":"Mukund","year":"2017","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"10.1016\/j.jhep.2025.08.001_bib421","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12880-023-00977-9","article-title":"Performance of spleen stiffness measurement by 2D-shear wave elastography in evaluating the presence of high-risk varices: comparative analysis of idiopathic portal hypertension versus hepatitis B virus","volume":"23","author":"Zhou","year":"2023","journal-title":"BMC Med Imaging"},{"issue":"2","key":"10.1016\/j.jhep.2025.08.001_bib422","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/HEP.0000000000001004","article-title":"Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder","volume":"81","author":"Moga","year":"2025","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib423","series-title":"Performance of spleen stiffness measurement by vibration controlled transient elastography to rule out high-risk varices in patients with chronic extrahepatic portal vein obstruction without cirrhosis","author":"Moga","year":"2024"},{"key":"10.1016\/j.jhep.2025.08.001_bib424","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib426","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.20990","article-title":"Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome","volume":"43","author":"Hern\u00e1ndez-Guerra","year":"2006","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib427","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0016-5085(87)90028-X","article-title":"Portal hemodynamics in idiopathic portal hypertension (Banti\u2019s syndrome). Comparison with chronic persistent hepatitis and normal subjects","volume":"92","author":"Ohnishi","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib428","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib429","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/j.gastro.2010.06.017","article-title":"Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension","volume":"139","author":"Sarin","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib430","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s10620-005-2877-1","article-title":"Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate\/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients","volume":"50","author":"Sarin","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2025.08.001_bib431","doi-asserted-by":"crossref","unstructured":"Vanderschueren E, Laleman W, Bonne L, et al. Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurement vs. Transjugular Balloon Occlusion Measurement in Patients with Cirrhosis (ENCOUNTER): A Bicentric EU Study. JHEP Rep. Available at: https:\/\/doi.org\/10.1016\/j.jhepr.2025.101466 [Accessed June 30, 2025].","DOI":"10.1016\/j.jhepr.2025.101466"},{"key":"10.1016\/j.jhep.2025.08.001_bib432","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/bloodadvances.2022007397","article-title":"Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study","volume":"6","author":"Ageno","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jhep.2025.08.001_bib433","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1038\/s41375-021-01279-1","article-title":"Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients","volume":"35","author":"Barbui","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jhep.2025.08.001_bib434","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0016-5085(86)90855-3","article-title":"Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study","volume":"90","author":"Valla","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.08.001_bib435","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.jhep.2025.08.001_bib436","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","article-title":"Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors","volume":"31","author":"Denninger","year":"2000","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib437","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study","volume":"96","author":"Janssen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2025.08.001_bib438","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Review article: prescribing medications in patients with cirrhosis - a practical guide","volume":"37","author":"Lewis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.08.001_bib439","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","author":"European Association for the Study of the Liver","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib440","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2009.02.028","article-title":"Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes","volume":"51","author":"Rautou","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib441","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4254\/wjh.v9.i21.945","article-title":"Outcomes of pregnancy in patients with known Budd-Chiari syndrome","volume":"9","author":"Khan","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib442","first-page":"754","article-title":"Pregnancy outcomes in women with Budd Chiari Syndrome before onset of symptoms and after treatment","volume":"38","author":"Shukla","year":"2018","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib443","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/1471-0528.16915","article-title":"Pregnancy outcomes in women with Budd-Chiari syndrome or portal vein thrombosis - a multicentre retrospective cohort study","volume":"129","author":"Wiegers","year":"2022","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jhep.2025.08.001_bib444","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12664-022-01307-7","article-title":"Pregnancy outcomes in patients with Budd-Chiari syndrome: a tertiary care experience","volume":"42","author":"Biswas","year":"2023","journal-title":"Indian J Gastroenterol Off J Indian Soc Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib445","first-page":"676","article-title":"Is pregnancy safe with extrahepatic portal vein obstruction? An analysis","volume":"53","author":"Mandal","year":"2012","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jhep.2025.08.001_bib446","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jceh.2014.12.007","article-title":"Pregnancy and vascular liver disease","volume":"5","author":"Bissonnette","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib447","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2012.07.034","article-title":"Pregnancy in women with portal vein thrombosis: results of a multicentric European study on maternal and fetal management and outcome","volume":"57","author":"Hoekstra","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib448","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1447-0756.2010.01407.x","article-title":"Extra hepatic portal vein obstruction and pregnancy outcome: largest reported experience","volume":"37","author":"Aggarwal","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.jhep.2025.08.001_bib449","first-page":"454","article-title":"Navigating portal hypertension: unlocking safe passage to healthy pregnancy in EHPVO","volume":"44","author":"Shukla","year":"2024","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2025.08.001_bib450","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jhep.2018.08.007","article-title":"Pregnancy in idiopathic non-cirrhotic portal hypertension: a multicentric study on maternal and fetal management and outcome","volume":"69","author":"Andrade","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib451","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jhep.2025.08.001_bib452","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clinre.2020.03.007","article-title":"Pregnancy and vascular liver diseases: vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver","volume":"44","author":"Payanc\u00e9","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2025.08.001_bib453","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2020.02.010","article-title":"Patient reported outcomes as emerging biomarkers in chronic liver disease research","volume":"72","author":"Verma","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib454","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.32618","article-title":"Patient-centered care: key elements applicable to chronic liver disease","volume":"78","author":"Verma","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2025.08.001_bib455","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1185\/030079905X50624","article-title":"Patients\u2019 perceptions regarding oral anticoagulation therapy and its effect on quality of life","volume":"21","author":"Casais","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jhep.2025.08.001_bib456","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.jhep.2025.08.001_bib457","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13318-016-0353-2","article-title":"Optimizing the clinical use of carvedilol in liver cirrhosis using a physiologically based pharmacokinetic modeling approach","volume":"42","author":"Rasool","year":"2017","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jhep.2025.08.001_bib458","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2468-1253(19)30320-6","article-title":"Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"5","author":"Pose","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib459","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40264-017-0635-x","article-title":"Evidence-based recommendations to improve the safe use of drugs in patients with liver cirrhosis","volume":"41","author":"Weersink","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhep.2025.08.001_bib460","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4065\/mcp.2009.0534","article-title":"Pain management in the cirrhotic patient: the clinical challenge","volume":"85","author":"Chandok","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2025.08.001_bib461","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.08.001_bib462","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL Clinical Practice Guidelines on acute-on-chronic liver failure","volume":"79","author":"European Association for the Study of the Liver","year":"2023","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825024067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825024067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:46:11Z","timestamp":1774554371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825024067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":461,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0168827825024067"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.08.001","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EASL Clinical Practice Guidelines on vascular diseases of the liver","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}